| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $44.0M | +85.7% |
| SG&A Expense | $18.6M | +712.5% |
| Operating Income | -$62.6M | -2241.5% |
| Pre-tax Income | -$60.6M | -121.6% |
| Income Tax | $0 | — |
| Net Income | -$60.4M | -1800.7% |
| EPS (Basic) | -$2.09 | +98.5% |
| EPS (Diluted) | -$2.09 | +98.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.8M | — |
| Current Assets | $100.8M | — |
| Total Assets | $100.8M | -28.7% |
| Current Liabilities | $20.3M | +1010.5% |
| Total Liabilities | $21.3M | +174.4% |
| Stockholders' Equity | $59.3M | +878.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.1M | -1305.6% |
| Investing Cash Flow | -$8.0M | +33.3% |
| Financing Cash Flow | $121.3M | — |